Compromised endothelial function in transgender men taking testosterone.
Barbara I GulanskiClare A FlanneryPatricia R PeterCheryl A LeoneNina S StachenfeldPublished in: Clinical endocrinology (2019)
We have shown for the first time that in TGM the androgen-dominant hormonal milieu was associated with impaired endothelial function. Endothelial dysfunction precedes clinically detectable atherosclerotic plaque in the coronary arteries, so is an important marker for clinical cardiovascular risk. Therefore, attention to cardiovascular risk factors should be integral to the care of transgender men.
Keyphrases
- cardiovascular risk factors
- coronary artery disease
- cardiovascular disease
- middle aged
- hiv testing
- metabolic syndrome
- healthcare
- coronary artery
- palliative care
- working memory
- quality improvement
- men who have sex with men
- replacement therapy
- type diabetes
- heart failure
- affordable care act
- blood flow
- human immunodeficiency virus
- transcatheter aortic valve replacement